Ad
related to: latest developments in cancer research articles impact factor chart
Search results
Results From The WOW.Com Content Network
Cancer Cell is internationally regarded as one of the top cancer research and oncology journals. According to the Journal Citation Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly in print and online versions.
This article about an oncology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Cancer and Metastasis Reviews is a quarterly peer-reviewed medical review journal covering oncology and the development of new cancer treatments. It was established in 1982 and is published by Springer Science+Business Media .
Cancer Discovery is a monthly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research and clinical trials related to the study of cancer. The editors-in-chief are Lewis C. Cantley and Luis A. Diaz. [1] The journal was established in 2011. [1]
CA: A Cancer Journal for Clinicians is a bimonthly peer-reviewed medical journal published for the American Cancer Society by Wiley-Blackwell. The journal was established in 1950 and covers aspects of cancer research on diagnosis, therapy, and prevention. [1] The editor-in-chief is Arif Kamal. [2]
Oncogene received a 2023 impact factor of 6.9 and received Journal Citation Reports rankings of 18th out of 191 in the category Genetics & Heredity, 29th out of 205 in the category Cell Biology, 32nd out of 313 in the category Biochemistry & Molecular Biology, and 43rd out of 322 journals in the category Oncology.
The American Journal of Cancer Research is a medical journal established in 2011. [3] It covers all areas of clinical oncology and experimental cancer research and publishes review articles, original articles, and editorials. It is published by e-Century Publishing Corporation.
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.